Doppelgerz® active from A to Zinc, effervescent tablets with a taste of peach and passion fruit

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.004231.04.13
Date of registration and renewal:30.04.2013
Dosage form: & nbspTablets weighing 6.2 g.
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Composition: & nbspComposition: calcium carbonate, magnesium carbonate, potassium iodate, potassium glycerophosphate, ascorbic acid, D-alpha-tocopherol acetate, nicotinamide, calcium D-pantothenate, riboflavin phosphate, pyridoxine hydrochloride, thiamine hydrochloride, vitamin A acetate, folic acid, biotin, Phytomenadione (vitamin K), cholecalciferol, vitamin B12, zinc sulfate, sodium selenate, chromium trichloride, sodium molybdate, malic acid, citric acid, sodium hydrogen carbonate, flavoring, potato starch, sorbitol, sodium cyclamate, beet powder, saccharin sodium, on dence carbonate
Scope: & nbspFor sale to the population through the pharmacy network and specialized stores, the sales network departments as a biologically active food additive - an additional source of calcium, magnesium, zinc, iodine, phosphorus, selenium, chromium, molybdenum, vitamins: A, C, E, PP, D3 , B1, B2, B5, B6, B12, biotin, folic acid, phytomenadione.
Suggested Usage: & nbspOne tablet to dissolve in a glass of water, take adults once a day with meals. Duration of admission is 1 month. After a break of 1 month, a second appointment is possible.
Contraindications:Individual intolerance of the components of the product, pregnancy, breast-feeding, predisposition to disorders of the gastrointestinal tract.
Special instructions:Before use, consult a physician.
Shelf life:3 years.
Storage conditions:Store in a dry place at a temperature of no higher than 25 ° C.
Research protocols:Expert Opinion of the Federal Antimonopoly Service of the Federal Service for Supervision of Consumer Rights and Welfare of the Federal Service for Supervision of Consumer Rights and Welfare No. 10-2 FT / 5113 of 14.11.2013.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp29.05.16
Instructions
Up